Suraksha Diagnostic IPO Day 2: Issue subscribed 20% so far; check offer size, price band and key dates

Suraksha Diagnostic IPO saw a lukewarm response from investors across categories on the second day of bidding on Monday, December 2. The mainboard issue was booked only 20% so far, as per the NSE data.

The investors across categories applied for over 26.32 lakh shares against 1.34 crore shares on offer.

The diagnostics service providers’ public issue has not received any bid from qualified institutional buyers (QIBs) yet. The company has reserved 38.37 lakh shares for this category.

The mainboard issue was booked 35% in the retail individual investors’ category. The retail segment received bids for 23.78 lakh shares against 67.16 lakh shares on offer.

The non-institutional investors booked their quota only 9% by applying for 2.52 lakh shares against 28.78 lakh shares reserved for the category.

Suraksha Diagnostic IPO: Offer size and price band

Retail investors interested in applying for the Suraksha Diagnostic IPO can place bids for a minimum of 34 shares in a single lot, which aggregates to an investment of ₹14,994.

The small non-institutional investors (sNIIs) can apply for the issue by placing bids for a minimum of 14 lots or 476 shares, which amounts to an investment of ₹2,09,916. Big NIIs (bNIIs) can bid for 67 lots, or 2,278 shares, aggregating to a minimum investment of ₹10,04,598.

Suraksha Diagnostic IPO allotment status, listing date

Suraksha Diagnostic IPO bidding window is scheduled to close on Tuesday, December 3. The share allotment status of Suraksha Diagnostic IPO is likely to be finalised on Wednesday, December 4.

After the finalisation of the public issue's share allotment status, refunds will be initiated for unsuccessful bidders on Thursday, December 5. The successful bidders will also receive shares of Suraksha Diagnostic in their demat accounts on Thursday. Suraksha Diagnostics shares will be listed on the NSE and BSE. The tentative IPO listing date has been fixed as December 6.

Suraksha Diagnostic IPO registrar

The book-running lead managers for the mainboard issue include ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited. The registrar for the issue is Kfin Technologies Limited.

Suraksha Diagnostic promoters

The promoters of the company include Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma. The promoters held a 61.07% stake in the company before the issue.

Suraksha Diagnostic key financials

Suraksha Diagnostics revenue for the June quarter of FY25 stood at ₹61.85 crore. The company’s profit-after-tax for Q1FY25 stood at ₹7.67 crore. The diagnostics service providers’ net worth stood at ₹187.05 crore.

Suraksha Diagnostic’s revenue for the fiscal ended March 31, 2024, increased by over 14% to ₹222.26 crore compared to ₹193.69 crore in the preceding financial year. The company’s net profit for FY24 surged by 281% to ₹23.13, growing from ₹6.07 crore in FY23. The net worth of the company grew more than 15% to ₹179.41 crore from ₹155.93 crore in the preceding fiscal.

About Suraksha Diagnostic

Suraksha Diagnostic Limited was incorporated in 2005. The company offers diagnostic services such as pathology and radiology testing. It also offers both online and offline medical consultation services. The company deploys advanced technology, such as digital pathology and artificial intelligence, to generate blood tests.